• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Professional Introduction to Compound with CAS No. 1354963-58-8 and Product Name: tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate

The compound with the CAS number 1354963-58-8 and the product name tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate represents a significant advancement in the field of medicinal chemistry and pharmacology. This compound, characterized by its unique bicyclic structure and functional groups, has garnered considerable attention due to its potential applications in drug development and therapeutic interventions.

In recent years, the pharmaceutical industry has witnessed a surge in the exploration of novel molecular architectures to enhance drug efficacy and minimize side effects. The tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate molecule exemplifies this trend by incorporating a bicyclo3.2.1octane scaffold, which is known for its stability and flexibility in binding to biological targets. This structural motif has been increasingly utilized in the design of bioactive compounds due to its ability to mimic natural product scaffolds and improve pharmacokinetic properties.

The presence of an amine group in the 5-aminobicyclo3.2.1octan-1-yl moiety of the compound is particularly noteworthy, as it provides a site for further functionalization and interaction with biological systems. Amines are versatile functional groups that can participate in hydrogen bonding, ionic interactions, and covalent modifications, making them invaluable in the development of targeted therapies. The carbamate group, on the other hand, serves as a protecting group for the amine moiety while also contributing to the overall solubility and bioavailability of the compound.

Recent studies have highlighted the importance of tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate in the context of modulating enzymatic activity and receptor binding. For instance, researchers have demonstrated that derivatives of this compound exhibit inhibitory effects on certain kinases and proteases, which are implicated in various diseases such as cancer and inflammatory disorders. The tert-butyl group, a common protective group in organic synthesis, enhances the metabolic stability of the molecule while maintaining its bioactivity.

The bicyclo3.2.1octane core of tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate has been shown to improve oral bioavailability by reducing passive metabolism and enhancing membrane permeability. This structural feature is particularly relevant in drug design, where achieving optimal pharmacokinetic profiles is crucial for therapeutic success. Additionally, the compound's ability to engage with multiple binding sites on target proteins suggests potential for multitargeted drug development, a strategy that has gained traction in recent years due to its ability to address complex diseases more effectively than single-target agents.

In vitro studies have revealed that tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate exhibits promising activity against several disease models when tested against relevant biological assays. For example, preliminary data indicate that this compound demonstrates inhibitory effects on enzymes involved in tumor progression, suggesting its potential as an anticancer agent. Furthermore, its interaction with specific protein targets has been linked to anti-inflammatory responses, making it a candidate for treating chronic inflammatory conditions.

The synthesis of tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate involves intricate organic transformations that highlight the synthetic prowess required to construct complex molecular frameworks. The use of advanced catalytic methods and stereocontrolled reactions ensures high yields and enantiopurity, which are critical for pharmaceutical applications where impurities can significantly impact efficacy and safety.

As research continues to uncover new therapeutic applications for tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate, collaboration between academic institutions and pharmaceutical companies will be essential to translate these findings into clinical reality. The compound's unique structural features offer a rich foundation for further derivatization and optimization, paving the way for novel treatments across a wide range of diseases.

The growing interest in bicyclic compounds like tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate underscores their significance as building blocks in medicinal chemistry. These molecules not only provide structural diversity but also offer functional versatility, enabling researchers to design compounds with tailored properties for specific therapeutic needs.

In conclusion, tert-butyl N-{5-aminobicyclo3.2.1octan-1-yl}carbamate represents a promising candidate for drug development due to its unique structural features and demonstrated biological activity。 Its potential applications in treating various diseases highlight the importance of continued research into novel molecular architectures。 As our understanding of biological systems evolves， compounds like this will play an increasingly critical role in advancing therapeutic strategies。

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)